These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 33067432)
1. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Valle S; Alcalá S; Martin-Hijano L; Cabezas-Sáinz P; Navarro D; Muñoz ER; Yuste L; Tiwary K; Walter K; Ruiz-Cañas L; Alonso-Nocelo M; Rubiolo JA; González-Arnay E; Heeschen C; Garcia-Bermejo L; Hermann PC; Sánchez L; Sancho P; Fernández-Moreno MÁ; Sainz B Nat Commun; 2020 Oct; 11(1):5265. PubMed ID: 33067432 [TBL] [Abstract][Full Text] [Related]
2. The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells. López-Gil JC; García-Silva S; Ruiz-Cañas L; Navarro D; Palencia-Campos A; Giráldez-Trujillo A; Earl J; Dorado J; Gómez-López G; Monfort-Vengut A; Alcalá S; Gaida MM; García-Mulero S; Cabezas-Sáinz P; Batres-Ramos S; Barreto E; Sánchez-Tomero P; Vallespinós M; Ambler L; Lin ML; Aicher A; García García de Paredes A; de la Pinta C; Sanjuanbenito A; Ruz-Caracuel I; Rodríguez-Garrote M; Guerra C; Carrato A; de Cárcer G; Sánchez L; Nombela-Arrieta C; Espinet E; Sanchez-Arevalo Lobo VJ; Heeschen C; Sainz B Gut; 2024 Aug; 73(9):1489-1508. PubMed ID: 38754953 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer stem cells: A state or an entity? Hermann PC; Sainz B Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664 [TBL] [Abstract][Full Text] [Related]
4. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238 [TBL] [Abstract][Full Text] [Related]
5. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes. Ai J; Wörmann SM; Görgülü K; Vallespinos M; Zagorac S; Alcala S; Wu N; Kabacaoglu D; Berninger A; Navarro D; Kaya-Aksoy E; Ruess DA; Ciecielski KJ; Kowalska M; Demir IE; Ceyhan GO; Heid I; Braren R; Riemann M; Schreiner S; Hofmann S; Kutschke M; Jastroch M; Slotta-Huspenina J; Muckenhuber A; Schlitter AM; Schmid RM; Steiger K; Diakopoulos KN; Lesina M; Sainz B; Algül H Gastroenterology; 2021 Jul; 161(1):318-332.e9. PubMed ID: 33819482 [TBL] [Abstract][Full Text] [Related]
7. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers. Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735 [TBL] [Abstract][Full Text] [Related]
8. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381 [TBL] [Abstract][Full Text] [Related]
9. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer. Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R Cancer Lett; 2019 Sep; 459():204-215. PubMed ID: 31199988 [TBL] [Abstract][Full Text] [Related]
10. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325 [TBL] [Abstract][Full Text] [Related]
11. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma. Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402 [TBL] [Abstract][Full Text] [Related]
12. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer. Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms. Cioffi M; Trabulo S; Hidalgo M; Costello E; Greenhalf W; Erkan M; Kleeff J; Sainz B; Heeschen C Clin Cancer Res; 2015 May; 21(10):2325-37. PubMed ID: 25717063 [TBL] [Abstract][Full Text] [Related]
14. Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells. Fabian A; Stegner S; Miarka L; Zimmermann J; Lenk L; Rahn S; Buttlar J; Viol F; Knaack H; Esser D; Schäuble S; Großmann P; Marinos G; Häsler R; Mikulits W; Saur D; Kaleta C; Schäfer H; Sebens S Cancer Lett; 2019 Jul; 453():95-106. PubMed ID: 30930235 [TBL] [Abstract][Full Text] [Related]
15. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer. Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335 [TBL] [Abstract][Full Text] [Related]
16. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity. Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687 [TBL] [Abstract][Full Text] [Related]
17. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369 [TBL] [Abstract][Full Text] [Related]
18. Nestin and other putative cancer stem cell markers in pancreatic cancer. Matsuda Y; Kure S; Ishiwata T Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289 [TBL] [Abstract][Full Text] [Related]
19. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells. Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666 [TBL] [Abstract][Full Text] [Related]
20. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]